Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review

No abstract is available for this paper.

• Publication year

  2012

• Venue

  BJU International

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-410X.2012.11068.xPMID 22471401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long‐term endoscopic management of upper tract urothelial carcinoma: 20‐year single‐centre experience

  2012cited by this paper
• Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas : 2011 Update

  2011cited by this paper
• European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.

  2011cited by this paper
• Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?

  2011cited by this paper
• Prognostic factors for upper urinary tract urothelial carcinoma

  2011cited by this paper
• United States Renal Data System

  2011cited by this paper
• Narrow-band Imaging Digital Flexible Ureteroscopy in Detection of Upper Urinary Tract Transitional-Cell Carcinoma: Initial Experience

  2011cited by this paper
• Third Prize: The Role of Endoscopic Nephron-Sparing Surgery in the Management of Upper Tract Urothelial Carcinoma

  2011cited by this paper
• Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management.

  2011cited by this paper
• EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

  2011cited by this paper
• Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival.

  2010cited by this paper
• Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.

  2010cited by this paper
• Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses.

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy

  2010cited by this paper
• A delay in radical nephroureterectomy can lead to upstaging

  2010cited by this paper
• Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma.

  2010cited by this paper
• Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.

  2010cited by this paper
• Photodynamic diagnosis (PDD) for upper urinary tract transitional cell carcinoma (UT-TCC): evolution of a new technique.

  2010cited by this paper
• Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours.

  2010cited by this paper
• A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?

  2009cited by this paper
• What Is the Cost of Maintaining a Kidney in Upper-Tract Transitional-Cell Carcinoma? An Objective Analysis of Cost and Survival

  2009cited by this paper
• Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

  2009cited by this paper
• Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma

  2009cited by this paper
• 2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections

  2009cited by this paper
• Small Endoscopic Biopsies of the Ureter and Renal Pelvis: Pathologic Pitfalls

  2009cited by this paper
• Correlation of Upper-Tract Cytology, Retrograde Pyelography, Ureteroscopic Appearance, and Ureteroscopic Biopsy with Histologic Examination of Upper-Tract Transitional Cell Carcinoma

  2008cited by this paper
• CONSERVATIVE MANAGEMENT IN SELECTED PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA COMPARES FAVOURABLY WITH EARLY RADICAL SURGERY

  2008cited by this paper
• Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery

  2008cited by this paper
• Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract

  2008cited by this paper
• Ureteroscopic Management of Upper-Tract Urothelial Cancer: An Exciting Nephron-Sparing Option or an Unacceptable Risk?

  2008cited by this paper
• Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

  2008cited by this paper
• Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.

  2008cited by this paper
• Imperative indications for conservative management of upper tract transitional cell carcinoma.

  2007cited by this paper
• 415: Does Adjuvant BCG Therapy Reduce the Incidence or Time to Recurrence in Upper Tract Transitional Cell Carcinoma? A 20 Year Experience

  2007cited by this paper
• Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.

  2007cited by this paper
• Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy.

  2007cited by this paper
• Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome.

  2007cited by this paper
• The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging

  2007cited by this paper
• Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B.

  2007cited by this paper
• Endourologic Management of Patients with Upper-Tract Transitional-Cell Carcinoma: Long-Term Follow-up in a Single Center

  2007cited by this paper
• Setting a New Standard for Topical Therapy of Upper-Tract Transitional-Cell Carcinoma: BCG and Interferon-α2B

  2007cited by this paper
• Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.

  2007cited by this paper
• Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.

  2006cited by this paper
• Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

  2006cited by this paper
• Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies

  2005cited by this paper
• Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.

  2005cited by this paper
• A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract

  2005cited by this paper
• Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup.

  2004cited by this paper
• Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma.

  2004cited by this paper
• Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.

  2004cited by this paper
• Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma.

  2003cited by this paper
• Endoscopic management of upper urinary tract transitional cell carcinoma

  2003cited by this paper
• Percutaneous management of renal pelvic urothelial tumors: long-term followup.

  2003cited by this paper
• Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment.

  2003cited by this paper
• Transurethral endoscopic treatment of upper urinary tract tumors using a holmium:YAG laser

  2003cited by this paper
• Role of ureteroscopic biopsy in the management of upper urinary tract malignancy

  2003cited by this paper
• Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression.

  2003cited by this paper
• Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter.

  2002cited by this paper
• Clinical outcome of bacillus Calmette‐Guérin perfusion therapy for carcinoma in situ of the upper urinary tract

  2002cited by this paper
• Totally Endoscopic Management of Upper Tract Transitional-Cell Carcinoma

  2002cited by this paper
• Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.

  2002cited by this paper
• Conservative management of upper urinary tract tumors.

  2002cited by this paper
• Intrarenal bacillus Calmette‐Guérin therapy for carcinoma in situ of the upper urinary tract: long‐term follow‐up and natural course in cases of failure

  2001cited by this paper
• Transitional-Cell Carcinoma of the Renal Pelvis: Ureteroscopic and Percutaneous Approach

  2001cited by this paper
• Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis.

  2000cited by this paper
• Bacillus Calmette–Guérin Perfusion Therapy for the Treatment of Transitional Cell Carcinoma in situ of the Upper Urinary Tract

  2000cited by this paper
• Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome.

  2000cited by this paper
• Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach.

  2000cited by this paper
• [Endourologic treatment of transitional cell carcinoma of the upper urinary tract].

  2000cited by this paper
• Primary percutaneous approach to upper urinary tract transitional cell carcinoma.

  2000cited by this paper
• 13-year experience with percutaneous management of upper tract transitional cell carcinoma.

  1999cited by this paper
• Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney.

  1999cited by this paper
• Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies.

  1999cited by this paper
• 13-Year Survival Comparison of Percutaneous and Open Nephroureterectomy Approaches for Management of Transitional Cell Carcinoma of Renal Collecting System: Equivalent Outcomes

  1999cited by this paper
• Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma.

  1999cited by this paper
• New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma.

  1998cited by this paper
• Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

  1998cited by this paper
• Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma.

  1997cited by this paper
• Ureteroscopic biopsy: technique and specimen preparation.

  1997cited by this paper
• Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma.

  1997cited by this paper
• Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.

  1997cited by this paper
• Long-term ureteroscopic management of low-grade transitional cell carcinoma of the upper urinary tract.

  1996cited by this paper
• Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors.

  1996cited by this paper
• Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.

  1996cited by this paper
• Long-term ureteroscopic management of low-grade transitional cell carcinoma of the upper urinary tract.

  1996cited by this paper
• Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma.

  1996cited by this paper
• Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience.

  1995cited by this paper
• Percutaneous nephroscopic resection of renal pelvic tumors.

  1995cited by this paper
• Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis.

  1995cited by this paper
• Definitive tumor resection and percutaneous bacille Calmette-Guérin for management of renal pelvic transitional cell carcinoma in solitary kidneys.

  1995cited by this paper
• Conservative Treatment of Upper Urinary Tract Tumors with Nd:YAG Laser

  1994cited by this paper
• Ureteroscopic management of transitional cell tumors.

  1994cited by this paper
• Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.

  1993cited by this paper
• Endourologic Treatment of Transitional Cell Carcinoma of the Upper Urinary Tract

  1992cited by this paper
• Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer.

  1989cited by this paper
• Laser treatment of ureteral tumors.

  1989cited by this paper
• Percutaneous treatment of transitional cell carcinoma of the upper urinary tract.

  1988cited by this paper

• Single-position versus traditional retroperitoneal laparoscopic nephroureterectomy for UTUC: long-term survival and perioperative outcomes.

  2026cites this paper
• The role of MRI in detection and staging of upper urinary tract cancer: a systematic review of the literature.

  2026cites this paper
• Urothelkarzinom des oberen Harntrakts – lokalisiert: Histopathologie, Molekulargenetik und klinische Besonderheiten

  2025cites this paper
• Competing risk analysis for predicting distant metastasis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy: based on a large dataset from a national medical center.

  2025cites this paper
• Primary Mid-ureter Squamous Cell Carcinoma: A Diagnostic Conundrum in the Absence of Traditional Risk Factors

  2025cites this paper
• Direct head-to-head comparison between neoadjuvant and adjuvant chemotherapy in upper tract urothelial carcinoma: A systematic review and meta-analysis.

  2025cites this paper
• Post-Surgical Outcomes of Kidney-Sparing Surgery vs. Radical Nephroureterectomy for Upper-Tract Urothelial Cancer in a Propensity-Weighted Cohort

  2025cites this paper
• Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group.

  2025cites this paper
• A Systematic Review of Intracavitary Therapies for Upper Tract Urothelial Carcinoma.

  2025cites this paper
• Clinical analysis of percutaneous kidney-sparing surgery for upper tract urothelial carcinoma

  2025cites this paper
• Systematic biopsies of the upper urinary tract: a tool to improve the diagnostic accuracy of ureteroscopy and characterization of upper tract urothelial cancer

  2025cites this paper
• Advancements in Hydrogel-Based Therapies as Non-surgical Alternatives for Urothelial Carcinoma: Ongoing Research and New Insights

  2025cites this paper
• European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update.

  2025cites this paper
• Editorial Comment on “The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study”

  2024cites this paper
• Cumulative morbidity of ureteroscopy for upper tract urothelial carcinoma.

  2024cites this paper
• A new nomogram for predicting extraurothelial recurrence in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy

  2024cites this paper
• An evaluation of mitomycin-containing reverse thermal gel for the treatment of low-grade upper tract urothelial carcinoma

  2024influential citation
• Endoscopic Cryoablation Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

  2024cites this paper
• Using apparent diffusion coefficient maps and radiomics to predict pathological grade in upper urinary tract urothelial carcinoma

  2024cites this paper
• Sarcomatoid renal pelvis carcinoma: Experience of treatment at a single-institution.

  2024cites this paper
• Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal Gel

  2024cites this paper
• Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan

  2024cites this paper
• Local Endoscopic Treatment of Low-Grade Urothelial Tumors in the Upper Urinary Tract—Oncological Outcome of a Consecutive Single-Center Series of 118 Patients

  2024cites this paper
• Role of Chemoablation Using UGN-101 in Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Available Evidence

  2024cites this paper
• Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ.

  2024cites this paper
• Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma.

  2024cites this paper
• Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance

  2024cites this paper
• The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser Vaporization

  2024cites this paper
• Measurement of tissue optical properties in the 400 to 700 nm range to assess light penetration depths for laser treatment of upper tract urothelial carcinomas

  2024cites this paper
• Role of Neoadjuvant Chemotherapy on Pathological, Functional, and Survival Outcomes of Upper Tract Urothelial Carcinoma Patients: A Systematic Review and Meta-Analysis

  2024cites this paper
• Immune checkpoint inhibitors in high‐grade upper tract urothelial carcinoma: Paradigm shift emphasizing organ preservation

  2024cites this paper
• A Propensity Score–Matched Analysis of the Impact of Carcinoma In Situ on the Clinical Outcomes in Patients with Upper Tract Urothelial Carcinomas—A Nationwide Multi-Institutional Cohort Study

  2024cites this paper
• Patient-specific targeted analysis of circulating tumour DNA in plasma is feasible and may be a potential biomarker in UTUC

  2023cites this paper
• A novel nomogram for predicting extraurothelial recurrence in patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy

  2023cites this paper
• The thermal effect of lasers in urology: a review article

  2023cites this paper
• Overview, Diagnosis, and Perioperative Systemic Therapy of Upper Tract Urothelial Carcinoma

  2023cites this paper
• Intravesical Therapy for Upper Urinary Tract Urothelial Carcinoma: A Comprehensive Review

  2023cites this paper
• Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma

  2023cites this paper
• The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study

  2023cites this paper
• Editorial Comment to Learning from the past and present to change the future: Endoscopic management of upper urinary tract urothelial carcinoma

  2023cites this paper
• Endoscopic excision versus radical nephroureterectomy for non-muscle invasive upper tract urothelial carcinoma: A population-based large cohort study

  2023cites this paper
• Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

  2023cites this paper
• Advances in chemoablation in upper tract urothelial carcinoma: overview of indications and treatment patterns

  2023cites this paper
• Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma.

  2023cites this paper
• Learning from the past and present to change the future: Endoscopic management of upper urinary tract urothelial carcinoma

  2023cites this paper
• Correlation between the timing of diagnostic ureteroscopy for upper tract urothelial cancer and intravesical recurrence after radical nephroureterectomy

  2023cites this paper
• Carbon‐ion radiotherapy for inoperable upper tract ureteral cancer

  2023cites this paper
• Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

  2023cites this paper
• Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma

  2023cites this paper
• Comparison of different prediction tools for the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a propensity-matched analysis

  2023cites this paper
• 450-nm blue diode laser: a novel medical apparatus for upper tract urothelial lesions

  2023cites this paper
• Do Urine Cytology and FISH Analysis Have a Role in the Follow-Up Protocol of Upper Tract Urothelial Carcinoma?

  2023cites this paper
• A Review of How Lasers Are Used in UTUC Surgery: Can the Choice of Laser Affect Outcomes?

  2023influential citation
• The Role of Local Agents for the Treatment of Localized Upper Tract Urothelial Carcinoma: A Review of the Current Evidence

  2023cites this paper
• Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis

  2022cites this paper
• Case report: Significant benefits of tislelizumab combined with anlotinib in first-line treatment of metastatic renal pelvic urothelial carcinoma with sarcomatoid carcinoma differentiation

  2022cites this paper
• Intravesical recurrence factors and outcome after radical nephroureterectomy for upper tract urothelial carcinoma: Multivariate analysis with propensity score matching

  2022cites this paper
• Percutaneous methods for the treatment of urothelial tumors of the pyelocaliceal system ( case report and literature review )

  2022cites this paper
• Endoscopic Ablation of Upper Tract Urothelial Carcinoma: A Report of Two Cases with Long Disease Recurrence-Free Periods.

  2022cites this paper
• Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma

  2022cites this paper
• S-phase – an independent prognostic marker in upper tract urothelial carcinoma

  2022cites this paper
• Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers

  2022cites this paper
• Trattamento conservativo dei tumori della via escretrice superiore

  2022cites this paper
• Tratamiento conservador de los tumores de la vía excretora superior

  2022cites this paper
• MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?

  2022cites this paper
• Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience

  2022cites this paper
• Comparing costs of renal preservation versus radical nephroureterectomy management among patients with non-metastatic upper tract urothelial carcinoma.

  2022cites this paper
• Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study.

  2022cites this paper
• Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?

  2022cites this paper
• Traitement conservateur des tumeurs de la voie excrétrice supérieure

  2021cites this paper
• Modelo impreso en 3D para entrenamiento en ureteroscopia flexible, una opción de bajo coste para el entrenamiento quirúrgico

  2021cites this paper
• Ureteral urothelial carcinoma with squamous cell carcinoma and sarcomatoid carcinoma differentiation: a case report

  2021cites this paper
• Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma.

  2021cites this paper
• Adjuvant Intraluminal Therapies in Upper Urinary Tract Urothelial Tumors

  2021cites this paper
• Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma

  2021cites this paper
• Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma

  2021cites this paper
• The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma.

  2021cites this paper
• Use of F-18 FDG PET/CT Through Delayed Diuretic Imaging for Preoperative Evaluation of Upper Urinary Tract-Occupying Lesions

  2021cites this paper
• Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider

  2021cites this paper
• Risk Stratification of Upper Tract Urothelial Carcinoma for Kidney-Sparing Surgery

  2021cites this paper
• Role of Ureteroscopy in Treatment of Upper Tract Urothelial Carcinoma

  2021cites this paper
• A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients

  2021cites this paper
• Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report

  2021cites this paper
• Surgery for Bladder and Upper Tract Urothelial Cancer.

  2021cites this paper
• Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma

  2021cites this paper
• Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma

  2021cites this paper
• The use of endoscopic combined intrarenal surgery as an additional approach to upper urinary tract urothelial carcinoma: Our Experience

  2021cites this paper
• 3D printed model for flexible ureteroscopy training, a low-cost option for surgical training.

  2021cites this paper
• Endoscopic Treatment for Large Multifocal Upper Tract Urothelial Carcinoma.

  2020cites this paper
• Diagnostic accuracy of photodynamic diagnosis for upper urinary tract urothelial carcinoma: A systematic review and meta-analysis.

  2020cites this paper
• Endoscopic thulium laser ablation of upper tract urothelial carcinoma: A retrospective study with subgroup analyses

  2020cites this paper
• Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes

  2020influential citation
• Outcomes of endoscopic management of upper tract urothelial carcinoma

  2020influential citation
• Risk stratification for upper tract urinary carcinoma

  2020cites this paper
• Delayed post-diuretic 18F-FDG PET/CT for preoperative evaluation of renal pelvic cancer

  2020cites this paper
• Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.

  2020cites this paper
• Upper Tract Urothelial Carcinoma

  2020cites this paper
• Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management

  2020cites this paper
• Complications Associated with Ureteroscopic Management of Upper Tract Urothelial Carcinoma.

  2020cites this paper
• Re: Primary Chemoablation of Low-grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-containing Reverse Thermal Gel (OLYMPUS): An Open-label, Single-arm, Phase 3 Trial.

  2020cites this paper